1. Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders 
Robert P. Hirten, Marietta Iacucci, Shailja Shah, Subrata Ghosh, Jean-Frederic Colombel 
Clinical Gastroenterology and Hepatology 
Volume 16, Issue 9, Pages (September 2018)
DOI: /j.cgh
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
Combinations of biologic agents that have been described in the published literature. Therapeutic agents are connected based on the disease state in which the combination was used with the mechanism of action of each treatment highlighted. APC, antigen-presenting cell; BCMA, B-cell maturation antigen; BLyS, B-lymphocyte stimulator; FcγR, Fc receptors for IgG; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; ILC, innate lymphoid cells; NK, natural killer T cell; TACI, transmembrane activator and calcium modulator and cyclophilin ligand injector; Th, T-helper cell.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions